In a major stride for Indian healthcare, Meril, one of the country’s leading medical device companies, unveiled the Mizzo Endo 4000, a next-generation soft tissue surgical robotic system. The system integrates AI-powered 3D anatomical mapping, 5G-enabled telesurgery, and global collaboration features, aiming to enhance surgical precision and accessibility nationwide.
The Mizzo Endo 4000 is designed for a wide range of specialties including general surgery, gynaecology, urology, thoracic, colorectal, bariatric, hepatobiliary, ENT, gastrointestinal, and oncology procedures. With its open console design and real-time AI guidance, surgeons can now perform complex operations remotely, bringing world-class expertise to underserved regions. Advanced robotic arms with audio-visual feedback, universal visit carts for seamless operating room integration, and DICOM viewing technology for precise pre-visualization underline the system’s cutting-edge capabilities.
Commenting on the launch, Vivek Shah, CEO of Meril, said, “The Mizzo Endo 4000 is not just a technological advancement—it is a statement of intent. It promises safer, minimally invasive procedures, faster recovery, and better outcomes, positioning India as a global MedTech hub.” In Kolkata, hospitals and surgical centres have welcomed the announcement, anticipating increased adoption of robotic surgery to improve patient outcomes and efficiency. Industry analysts note that the city’s thriving healthcare market, with its network of multi-specialty hospitals, is well poised to integrate this advanced technology, further strengthening India’s leadership in surgical robotics. With operations in over 150 countries and 12 global academies, Meril’s launch of Mizzo Endo 4000 marks a defining moment in India’s journey toward healthcare innovation and global MedTech prominence.